Form S-3 Dermata Therapeutics Inc For: 9 October
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Dermata Therapeutics Inc (DRMA)
Dermata Therapeutics Inc stock price live, this page displays NASDAQ DRMA stock exchange data. View the DRMA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Dermata Therapeutics Inc real time stock price chart below.
What Is the Dermata Therapeutics Inc Stock Price Today?
The Dermata Therapeutics Inc stock price today is 0.8896.
What Is the Stock Symbol for Dermata Therapeutics Inc?
The stock symbol for Dermata Therapeutics Inc is "DRMA."
What Stock Exchange Does Dermata Therapeutics Inc Trade On?
Dermata Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Dermata Therapeutics Inc a Good Stock to Buy?
Determining whether Dermata Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DRMA quote. (ISIN: US2498455045)
What Is the Dermata Therapeutics Inc Stock Price Today?
The Dermata Therapeutics Inc stock price today is 0.8896.
What Is the Stock Symbol for Dermata Therapeutics Inc?
The stock symbol for Dermata Therapeutics Inc is "DRMA."
What Stock Exchange Does Dermata Therapeutics Inc Trade On?
Dermata Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Dermata Therapeutics Inc a Good Stock to Buy?
Determining whether Dermata Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DRMA quote. (ISIN: US2498455045)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.8867
1.0102
52 wk Range
0.8867
4.6600
Trading near 52-week Low
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.88671.0102
52 wk Range
0.88674.6600
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
DRMA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
4.0000
Upside
+349.64%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
- Form S-3 Dermata Therapeutics Inc For: 9 October
- Investing.com
Dermata opens preorders for Tome skincare product- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 4.0000
(+349.64% Upside)
Earnings
Latest Release
Aug 11, 2026
EPS / Forecast
-0.74 / -0.55
Revenue / Forecast
-- / --
Compare DRMA to Peers and Sector
Metrics to compare | DRMA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDRMAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.4x | −2.9x | −0.3x | |
PEG Ratio | −0.01 | 0.03 | 0.00 | |
Price/Book | 1.0x | 3.8x | 2.6x | |
Price / LTM Sales | - | 18.1x | 3.0x | |
Upside (Analyst Target) | 292.2% | 58.8% | 62.1% | |
Fair Value Upside | Unlock | 3.2% | 8.1% | Unlock |
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Dermata Therapeutics (DRMA) Stock Price Today?
The Dermata Therapeutics stock price today is 0.8896 USD.
What Stock Exchange Does Dermata Therapeutics Trade On?
Dermata Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Dermata Therapeutics?
The stock symbol for Dermata Therapeutics is "DRMA."
What Is the Dermata Therapeutics Market Cap?
As of today, Dermata Therapeutics market cap is 3.5800M USD.
What Is Dermata Therapeutics's Earnings Per Share (TTM)?
The Dermata Therapeutics EPS (TTM) is -3.3335.
When Is the Next Dermata Therapeutics Earnings Date?
Dermata Therapeutics will release its next earnings report on Nov 18, 2026.
From a Technical Analysis Perspective, Is DRMA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Dermata Therapeutics Stock Split?
Dermata Therapeutics has split 3 times.
How Many Employees Does Dermata Therapeutics Have?
Dermata Therapeutics has 9 employees.
What is the current trading status of Dermata Therapeutics (DRMA)?
As of Oct 13, 2026, Dermata Therapeutics (DRMA) is trading at a price of 0.8896 USD, with a previous close of 0.8896 USD. The stock has fluctuated within a day range of 0.8867 USD to 1.0102 USD, while its 52-week range spans from 0.8867 USD to 4.6600 USD.
What Is Dermata Therapeutics (DRMA) Price Target According to Analysts?
The average 12-month price target for Dermata Therapeutics is 4.0000 USD, with a high estimate of 4 USD and a low estimate of 4 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +349.64% Upside potential.
What Is the DRMA Premarket Price?
DRMA's last pre-market stock price is 1.0000 USD. The pre-market share volume is 1,120.0000, and the stock has decreased by -0.0200, or -1.9600%.
What Is the DRMA After Hours Price?
DRMA's last after hours stock price is 0.9000 USD, the stock has decreased by 0.0104, or 1.1700%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.